Drug · DIN 02438712
EGRIFTA
SINGLE-USE VIALS, DILUENT AND SYRINGES
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since September 30, 2022; first marketed June 23, 2015.
- Drug Identification Number (DIN)
- 02438712
- Company (DIN owner)
- Theratechnologies IncMontréal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Kit; Powder For Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Tesamorelin H01AC06
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TESAMORELIN (TESAMORELIN ACETATE) | 1 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 27, 2015: NOC 16731Supplement to a New Drug Submission (SNDS) · New strength 1 mg/vial
Other DINs named EGRIFTA
- DIN 02423677 · Cancelled Pre Market